Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

25.03
+0.35001.42%
Post-market: 24.99-0.0400-0.16%18:28 EDT
Volume:184.48K
Turnover:4.59M
Market Cap:60.31M
PE:- -
High:25.84
Open:24.74
Low:24.15
Close:24.68
52wk High:391.58
52wk Low:12.38
Shares:2.41M
Float Shares:2.41M
Volume Ratio:0.67
T/O Rate:7.66%
Dividend:1.98
Dividend Rate:7.91%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers Stock Plunges After FTC Sues over Alleged Privacy Violations

Dow Jones
·
Jul 30

Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading

MT Newswires Live
·
Jul 30

Hims & Hers Says FTC Lawsuit Disregards Substantial Evidence We Provided the Agency During Investigation

Reuters
·
Jul 30

Hims & Hers Health on FTC Lawsuit : We are Confident in Our Position and Will Vigorously Defend Ourselves Against These Baseless Claims

THOMSON REUTERS
·
Jul 30

Rpt: Hims & Hers on FTC Lawsuit: Lawsuit Disregards Substantial Evidence We Provided the FTC During Its Nearly Three-Year Investigation

THOMSON REUTERS
·
Jul 30

FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports

MT Newswires Live
·
Jul 30

Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap

THOMSON REUTERS
·
Jul 30

US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap

Reuters
·
Jul 30

Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says

THOMSON REUTERS
·
Jul 30

Hims & Hers Health (HIMS) Receives a Hold from Truist Financial

TIPRANKS
·
Jul 29

Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?

TIPRANKS
·
Jul 25

Hims & Hers falls -10.3%

TIPRANKS
·
Jul 25

Truist Raises Price Target on Hims & Hers Health to $27 From $23, Keeps Hold Rating

MT Newswires Live
·
Jul 24

Hims & Hers Health Inc : Truist Securities Raises Target Price to $27 from $23

THOMSON REUTERS
·
Jul 24

Moderately bullish activity in Hims and Hers Health with shares up 3.39%

TIPRANKS
·
Jul 24

Hims & Hers Health is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 24

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Reuters
·
Jul 24

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS
·
Jul 24